Advertisement

Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology

      Abstract

      Purpose

      To evaluate outcome in patients with base of skull meningiomas treated with modern high precision radiation therapy (RT) techniques.

      Patients and methods

      927 patients from three centers were treated with either radiosurgery or fractionated high-precision RT for meningiomas. Treatment planning was based on CT and MRI following institutional guidelines. For radiosurgery, a median dose of 13 Gy was applied, for fractionated treatments, a median dose of 54 Gy in 1.8 Gy single fractions was prescribed. Follow-up included a clinical examination as well as contrast-enhanced imaging. All patients were followed up prospectively after radiotherapy in the three departments within a strict follow-up regimen. The median follow-up time was 81 months (range 1–348 months).

      Results

      Median local control was 79 months (range 1–348 months). Local control (LC) was 98% at 1 year, 94% at 3 years, 92% at 5 years and 86% at 10 years. There was no difference between radiosurgery and fractionated RT. We analyzed the influence of higher doses on LC and could show that dose did not impact LC. Moreover, there was no difference between 54 Gy and 57.6 Gy in the fractionated group. Side effects were below 5% in both groups without any severe treatment-related complications.

      Discussion

      Based on the pooled data analysis this manuscript provides a large series of meningiomas of the skull base treated with modern high precision RT demonstrating excellent local control and low rates of side effects. Such data support the recommendation of RT for skull base meningiomas in the interdisciplinary tumor board discussions. The strong role of RT must influence treatment recommendations keeping in mind the individual risk–benefit profile of treatment alternatives.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Combs S.E.
        • et al.
        Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
        Radiother Oncol. 2013; 106: 186-191
        • Lettner S.
        • Kessel K.A.
        • Combs S.E.
        Complementary and alternative medicine in radiation oncology: Survey of patients’ attitudes.
        Strahlenther Onkol. 2017; 193: 419-425
        • Solda F.
        • et al.
        Long-term efficacy of fractionated radiotherapy for benign meningiomas.
        Radiother Oncol. 2013; 109: 330-334
        • Ernst-Stecken A.
        • et al.
        Radiosurgery of small skull-base lesions. No advantage for intensity-modulated stereotactic radiosurgery versus conformal arc technique.
        Strahlenther Onkol. 2005; 181: 336-344
        • Henze M.
        • et al.
        Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
        J Nucl Med. 2005; 46: 763-769
        • Baumert B.G.
        • Norton I.A.
        • Davis J.B.
        Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base.
        Int J Radiat Oncol Biol Phys. 2003; 57: 580-592
        • Steinvorth S.
        • et al.
        Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up.
        Radiother Oncol. 2003; 69: 177-182
        • Jalali R.
        • et al.
        High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location.
        Clin Oncol (R Coll Radiol). 2002; 14: 103-109
        • Gudjonsson O.
        • et al.
        Evaluation of the effect of high-energy proton irradiation treatment on meningiomas by means of 11C-L-methionine PET.
        Eur J Nucl Med. 2000; 27: 1793-1799
        • Kaul D.
        • et al.
        Meningioma of the skull base: long-term outcome after image-guided stereotactic radiotherapy.
        Cancer Radiother. 2014; 18: 730-735
        • Fokas E.
        • et al.
        Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients.
        Int J Radiat Oncol Biol Phys. 2014; 89: 569-575
        • Henzel M.
        • et al.
        Quality of life after stereotactic radiotherapy for meningioma: a prospective non-randomized study.
        J Neurooncol. 2013; 113: 135-141
        • Kessel K.A.
        • et al.
        High-precision radiotherapy for meningiomas: Long-term results and patient-reported outcome (PRO).
        Strahlenther Onkol. 2017;
        • Fokas E.
        • et al.
        Stereotactic radiotherapy of benign meningioma in the elderly: clinical outcome and toxicity in 121 patients.
        Radiother Oncol. 2014; 111: 457-462
        • Baumert B.G.
        • et al.
        Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma.
        Radiother Oncol. 2004; 72: 169-174
        • Becker G.
        • et al.
        Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma.
        Int J Radiat Oncol Biol Phys. 2002; 54: 1422-1429
        • Sethi R.A.
        • et al.
        Dose-response relationships for meningioma radiosurgery.
        Am J Clin Oncol. 2015; 38: 600-604
        • Deibert C.P.
        • Kondziolka D.
        Stereotactic radiosurgery used to manage a meningioma filling the posterior two-thirds of the superior sagittal sinus.
        J Neurosurg. 2013; 119: 1156-1158
        • Combs S.E.
        • et al.
        State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques.
        Radiat Oncol. 2012; 7: 226
        • Flickinger J.C.
        • et al.
        Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma.
        Int J Radiat Oncol Biol Phys. 2003; 56: 801-806
        • Kondziolka D.
        • et al.
        Long-term outcomes after meningioma radiosurgery: physician and patient perspectives.
        J Neurosurg. 1999; 91: 44-50
        • Kondziolka D.
        • Flickinger J.C.
        • Perez B.
        Judicious resection and/or radiosurgery for parasagittal meningiomas: outcomes from a multicenter review. Gamma Knife Meningioma Study Group.
        Neurosurgery. 1998; 43 (discussion 413-4): 405-413
        • Gudjonsson O.
        • et al.
        Stereotactic irradiation of skull base meningiomas with high energy protons.
        Acta Neurochir (Wien). 1999; 141: 933-940
        • Miralbell R.
        • et al.
        The role of radiotherapy in the treatment of subtotally resected benign meningiomas.
        J Neurooncol. 1992; 13: 157-164
        • Andrews D.W.
        • et al.
        Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery.
        Neurosurgery. 2002; 51 (discussion 903-4): 890-902
        • Mozes P.
        • et al.
        Volumetric response of intracranial meningioma after photon or particle irradiation.
        Acta Oncol. 2017; 56: 431-437
        • Simon F.
        • et al.
        Integrin-based meningioma cell migration is promoted by photon but not by carbon-ion irradiation.
        Strahlenther Onkol. 2015; 191: 347-355
        • Afshar-Oromieh A.
        • et al.
        Comparison of (6)(8)Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
        Neuro Oncol. 2015; 17: 312-319
        • Combs S.E.
        • et al.
        Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base.
        Acta Oncol. 2013; 52: 1504-1509
        • Combs S.E.
        • et al.
        Helical tomotherapy for meningiomas of the skull base and in paraspinal regions with complex anatomy and/or multiple lesions.
        Tumori. 2011; 97: 484-491
        • Combs S.E.
        • et al.
        Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region.
        Radiother Oncol. 2011; 98: 63-67
        • Astner S.T.
        • et al.
        Tumor shrinkage assessed by volumetric MRI in the long-term follow-up after stereotactic radiotherapy of meningiomas.
        Strahlenther Onkol. 2010; 186: 423-429
        • Galldiks N.
        • et al.
        PET imaging in patients with meningioma – Report of the RANO/PET Group.
        Neuro Oncol. 2017;
        • Goldbrunner R.
        • et al.
        EANO guidelines for the diagnosis and treatment of meningiomas.
        Lancet Oncol. 2016; 17: e383-e391
        • Ryttlefors M.
        • et al.
        Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography.
        Eur J Nucl Med Mol Imaging. 2016; 43: 1432-1443
        • Sindou M.
        • Nebbal M.
        • Guclu B.
        Cavernous sinus meningiomas: imaging and surgical strategy.
        Adv Tech Stand Neurosurg. 2015; 42: 103-121
        • Compter I.
        • et al.
        High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma. A multicentre study.
        Strahlenther Onkol. 2012; 188: 887-893
        • Astner S.T.
        • et al.
        Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas.
        Int J Radiat Oncol Biol Phys. 2008; 72: 1161-1167
        • Pasquier D.
        • et al.
        Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
        Int J Radiat Oncol Biol Phys. 2008; 71: 1388-1393
        • Milker-Zabel S.
        • et al.
        Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
        Int J Radiat Oncol Biol Phys. 2006; 65: 222-227
        • Pitz S.
        • et al.
        Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative.
        Br J Ophthalmol. 2002; 86: 1265-1268
        • Samii M.
        • Rosahl S.K.
        • Tatagiba M.S.
        Microsurgical removal of a petrous apex meningioma after stereotactic radiation: technical case report.
        Neurosurgery. 2001; 49 (discussion 219-20): 216-219
        • Alheit H.
        • et al.
        Stereotactically guided conformal radiotherapy for meningiomas.
        Radiother Oncol. 1999; 50: 145-150
        • Zweckberger K.
        • et al.
        Prospective analysis of neuropsychological deficits following resection of benign skull base meningiomas.
        J Neurosurg. 2017; : 1-7
        • Hug E.B.
        • et al.
        Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
        J Neurooncol. 2000; 48: 151-160
        • Adeberg S.
        • et al.
        Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas–clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
        Int J Radiat Oncol Biol Phys. 2012; 83: 859-864
        • Henzel M.
        • et al.
        Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study.
        Neurosurgery. 2006; 59 (discussion 1194): 1188-1194
        • Combs S.E.
        • et al.
        Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
        Radiother Oncol. 2015; 114: 378-383
        • Combs S.E.
        • et al.
        Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
        Radiother Oncol. 2013; 106: 175-180
        • Sandstrom H.
        • et al.
        Assessment of organs-at-risk contouring practices in radiosurgery institutions around the world - The first initiative of the OAR Standardization Working Group.
        Radiother Oncol. 2016; 121: 180-186